Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - OMEGA PROTEIN CORP | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Act of 1934
Date of Report (Date of earliest event reported): June 13, 2016
Omega Protein Corporation
(Exact name of registrant as specified in its charter)
Nevada
|
001-14003 |
76-0562134
|
2105 City West Blvd., Suite 500 Houston, Texas
|
77042 |
(713) 623-0060
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.133-4(c))
Item 8.01 Other Events
On June 13, 2016, Omega Protein Corporation (the “Company”) issued a press release containing a special bulletin from the Company’s Board of Directors to its stockholders. A copy of that press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 8.01 by reference.
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
(a) |
Exhibits. |
99.1 |
Text of Press Release dated June 13, 2016 titled “Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital’s Deficient Proxy Statement” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Omega Protein Corporation |
|
|
|
|
|
Dated: June 13, 2016 |
/s/ John D. Held |
| |
|
|
John D. Held |
|
|
|
Executive Vice President and General Counsel |
|